ArticleJournal of hepatocellular carcinoma2025
Integrating CEUS Imaging Features and LI-RADS Classification for Postoperative Early Recurrence Prediction in Solitary Hepatocellular Carcinoma: A Machine Learning-Based Prognostic Approach.
Article in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AI-Driven Predictive Models of Early Recurrence of HCC After Surgical Resection: A Systematic Review.Cancers · 2026Review
- Systematic evaluation and meta-analysis of the diagnostic accuracy of ultrasound contrast in predicting the efficacy of systemic therapy for advanced hepatocellular carcinoma.Translational cancer research · 2026Article
- Artificial Intelligence in the Diagnosis and Prognostic Stratification of Hepatocellular Carcinoma: Current Evidence, Clinical Applications, and Future Perspectives.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To develop and validate a machine learning (ML) model for predicting early postoperative recurrence in hepatocellular carcinoma (HCC) patients by integrating contrast-enhanced ultrasound (CEUS) features with Liver Imaging Reporting and Data System (LI-RADS) classification. Materials and Methods: A retrospective analysis was conducted on data from 279 patients who underwent surgical resection for HCC. CEUS-derived features, including the LI-RADS classification, were integrated with clinical and pathological variables to construct predictive models. Patients were randomly assigned to training (n = 196) and validation (n = 83) cohorts in a 7:3 ratio. Feature selection was performed using univariate Cox regression (p ≤ 0.05), and four ML algorithms-Random Survival Forest (RSF), Gradient Boosting Machine (GBM), CoxBoost, and XGBoost-were applied to develop recurrence prediction models. Model performance was evaluated using the concordance index (C-index), area under the curve (AUC), calibration curves, decision curve analysis (DCA), and Kaplan-Meier (KM) survival analysis. Results: Five significant features identified by univariate Cox regression were included in model development: microvascular invasion (MVI), tumor size, LI-RADS classification, tumor necrosis, and arterial enhancement patterns. Among the four ML algorithms, GBM achieved the best overall performance, with the following results. The C-index for 1-year and 2-year recurrence prediction was 0.802 and 0.735 in the training cohort, and 0.804 and 0.710 in the validation cohort, respectively. The corresponding AUCs were 0.820 and 0.764 in the training cohort, and 0.817 and 0.716 in the validation cohort. Feature importance analysis identified LI-RADS classification, MVI, and tumor size as the top three prognostic indicators, while KM survival analysis confirmed the model's ability to stratify patients into distinct risk groups (training cohort: Conclusion: The GBM-based ML model integrating CEUS imaging features and LI-RADS classification demonstrates potential for predicting early postoperative recurrence of HCC, which may assist in guiding follow-up strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.